Kore Private Wealth’s Editas Medicine EDIT Stock Holding History

Kore Private Wealth’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,000	Closed	-$29K	–	495
2020 Q2	$29K	Buy	+1,000	New	+$26.1K	0.01%	577

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kore Private Wealth's EDIT Position: Q3 2020 in Review

Kore Private Wealth sold out of Editas Medicine (EDIT) in Q3 2020, closing a stake of 1,000 shares — an estimated $29K sold.

Kore Private Wealth first reported a position in EDIT in Q2 2020 and held it in 1 quarter. The position peaked at $29K in Q2 2020. 239 funds tracked by Wall St. Rank hold EDIT as of Q3 2020.

Kore Private Wealth reported no remaining Editas Medicine position as of Q3 2020 after selling out during the quarter.
Kore Private Wealth sold 1,000 Editas Medicine shares in Q3 2020, an estimated $29K.
Kore Private Wealth first reported a position in Editas Medicine in Q2 2020 and held it in 1 quarter.
Kore Private Wealth's Editas Medicine position peaked at $29K in Q2 2020.
239 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.